These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30706775)

  • 1. Current Anti-Inflammatory Therapies and the Potential of Secretory Phospholipase A2 Inhibitors in the Design of New Anti-Inflammatory Drugs: A Review of 2012 - 2018.
    Sales TA; Marcussi S; Ramalho TC
    Curr Med Chem; 2020; 27(3):477-497. PubMed ID: 30706775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based grafting, mutation, and optimization of peptide inhibitors to fit in the active pocket of human secreted phospholipase A2: find new use of old Peptide agents with anti-inflammatory activity.
    Zhan C; Li S; Zhong Q; Zhou D
    Chem Biol Drug Des; 2015 Apr; 85(4):418-26. PubMed ID: 25187416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of two new antagonists of secretory PLA2 on TNF, iNOS, and COX-2 expression in activated macrophages.
    Baek SH; Yun SS; Kwon TK; Kim JR; Chang HW; Kwak JY; Kim JH; Kwun KB
    Shock; 1999 Dec; 12(6):473-8. PubMed ID: 10588517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretory phospholipase A2 inhibitors. Possible new anti-inflammatory agents.
    Tanaka K; Arita H
    Agents Actions Suppl; 1995; 46():51-64. PubMed ID: 7610991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel functions of bovine milk-derived alpha-lactalbumin: anti-nociceptive and anti-inflammatory activity caused by inhibiting cyclooxygenase-2 and phospholipase A2.
    Yamaguchi M; Yoshida K; Uchida M
    Biol Pharm Bull; 2009 Mar; 32(3):366-71. PubMed ID: 19252279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of secretory phospholipase A2 group IIA.
    Reid RC
    Curr Med Chem; 2005; 12(25):3011-26. PubMed ID: 16378502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of extracellular release of proinflammatory secretory phospholipase A2 (sPLA2) by sulfasalazine: a novel mechanism of anti-inflammatory activity.
    Pruzanski W; Stefanski E; Vadas P; Ramamurthy NS
    Biochem Pharmacol; 1997 Jun; 53(12):1901-7. PubMed ID: 9256165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of cyclooxygenase-2 by secretory phospholipases A2 in nerve growth factor-stimulated rat serosal mast cells is facilitated by interaction with fibroblasts and mediated by a mechanism independent of their enzymatic functions.
    Tada K; Murakami M; Kambe T; Kudo I
    J Immunol; 1998 Nov; 161(9):5008-15. PubMed ID: 9794438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group IIA secretory PLA2 inhibition by ursolic acid: a potent anti-inflammatory molecule.
    Nataraju A; Raghavendra Gowda CD; Rajesh R; Vishwanath BS
    Curr Top Med Chem; 2007; 7(8):801-9. PubMed ID: 17456043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases A
    Nikolaou A; Kokotou MG; Vasilakaki S; Kokotos G
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Jun; 1864(6):941-956. PubMed ID: 30905350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer-aided drug design guided by hydrogen/deuterium exchange mass spectrometry: A powerful combination for the development of potent and selective inhibitors of Group VIA calcium-independent phospholipase A
    Mouchlis VD; Morisseau C; Hammock BD; Li S; McCammon JA; Dennis EA
    Bioorg Med Chem; 2016 Oct; 24(20):4801-4811. PubMed ID: 27320659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cytoplasmic and secretory phospholipase A2 in intestinal epithelial cell prostaglandin E2 formation.
    Grossman EM; Longo WE; Mazuski JE; Panesar N; Kaminski DL
    Int J Surg Investig; 2000; 1(6):467-76. PubMed ID: 11729854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipase A2 inhibitors in development.
    Tibes U; Friebe WG
    Expert Opin Investig Drugs; 1997 Mar; 6(3):279-98. PubMed ID: 15989628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Rhamnetin as an Inhibitor of the Pharmacological Effect of Secretory Phospholipase A2.
    Novo Belchor M; Hessel Gaeta H; Fabri Bittencourt Rodrigues C; Ramos da Cruz Costa C; de Oliveira Toyama D; Domingues Passero LF; Dalastra Laurenti M; Hikari Toyama M
    Molecules; 2017 Aug; 22(9):. PubMed ID: 28858248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of arachidonic acid metabolism by the Andean crude drug Parastrephia lucida (Meyen) Cabrera.
    D'Almeida RE; Isla MI; Vildoza Ede L; Quispe C; Schmeda-Hirschmann G; Alberto MR
    J Ethnopharmacol; 2013 Dec; 150(3):1080-6. PubMed ID: 24432370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospholipase A2 Isoforms as Novel Targets for Prevention and Treatment of Inflammatory and Oncologic Diseases.
    Yarla NS; Bishayee A; Vadlakonda L; Chintala R; Duddukuri GR; Reddanna P; Dowluru KS
    Curr Drug Targets; 2016; 17(16):1940-1962. PubMed ID: 26212262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional site of endogenous phospholipase A2 inhibitor from python serum.
    Thwin MM; Satish RL; Chan ST; Gopalakrishnakone P
    Eur J Biochem; 2002 Jan; 269(2):719-27. PubMed ID: 11856333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of bioavailable inhibitors of secretory phospholipase A2.
    Blanchard SG; Andrews RC; Brown PJ; Gan LS; Lee FW; Sinhababu AK; Wheeler TN
    Pharm Biotechnol; 1998; 11():445-63. PubMed ID: 9760691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibitory effect of saPLIγ, a snake sourced PLA
    Zhang D; Li J; Sun S; Huang C
    Toxicon; 2018 Sep; 151():89-95. PubMed ID: 30003915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory drugs in the 21st century.
    Rainsford KD
    Subcell Biochem; 2007; 42():3-27. PubMed ID: 17612044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.